Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Frailty | 4 | 2024 | 58 | 2.790 |
Why?
|
| Lung Transplantation | 4 | 2023 | 175 | 2.140 |
Why?
|
| Solitary Pulmonary Nodule | 3 | 2020 | 138 | 1.880 |
Why?
|
| Lung Neoplasms | 7 | 2021 | 2262 | 1.610 |
Why?
|
| Pneumonectomy | 5 | 2021 | 196 | 1.560 |
Why?
|
| Kidney Transplantation | 5 | 2024 | 849 | 1.220 |
Why?
|
| Kidney Failure, Chronic | 2 | 2024 | 509 | 1.010 |
Why?
|
| Tracheal Stenosis | 2 | 2021 | 23 | 0.980 |
Why?
|
| Antibody Formation | 2 | 2021 | 171 | 0.930 |
Why?
|
| Frail Elderly | 1 | 2024 | 71 | 0.920 |
Why?
|
| Antibodies, Viral | 3 | 2021 | 293 | 0.910 |
Why?
|
| Graft Survival | 4 | 2022 | 884 | 0.890 |
Why?
|
| Graft Rejection | 5 | 2022 | 1065 | 0.870 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 1 | 2022 | 13 | 0.860 |
Why?
|
| Tracheal Neoplasms | 1 | 2021 | 8 | 0.800 |
Why?
|
| Tracheostomy | 1 | 2021 | 42 | 0.770 |
Why?
|
| Patient Selection | 3 | 2020 | 685 | 0.750 |
Why?
|
| Lung | 6 | 2022 | 1170 | 0.750 |
Why?
|
| Symptom Assessment | 1 | 2020 | 65 | 0.750 |
Why?
|
| Sarcopenia | 1 | 2019 | 13 | 0.720 |
Why?
|
| Intubation, Intratracheal | 1 | 2021 | 144 | 0.710 |
Why?
|
| Leukocytes | 2 | 2022 | 202 | 0.680 |
Why?
|
| Histocompatibility | 2 | 2015 | 71 | 0.660 |
Why?
|
| Bioengineering | 2 | 2014 | 12 | 0.640 |
Why?
|
| Mediastinal Neoplasms | 1 | 2018 | 46 | 0.630 |
Why?
|
| Postoperative Complications | 4 | 2021 | 2207 | 0.620 |
Why?
|
| Thyroid Neoplasms | 1 | 2022 | 408 | 0.610 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 306 | 0.610 |
Why?
|
| Angiography | 1 | 2018 | 208 | 0.600 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2017 | 30 | 0.600 |
Why?
|
| Bronchoscopy | 2 | 2021 | 152 | 0.580 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 449 | 0.570 |
Why?
|
| Body Mass Index | 1 | 2019 | 770 | 0.560 |
Why?
|
| Composite Tissue Allografts | 1 | 2015 | 7 | 0.540 |
Why?
|
| Histocompatibility Antigens | 1 | 2015 | 35 | 0.540 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 2601 | 0.510 |
Why?
|
| Skin Transplantation | 1 | 2015 | 172 | 0.490 |
Why?
|
| Humans | 31 | 2024 | 86643 | 0.480 |
Why?
|
| Transplantation, Heterologous | 1 | 2014 | 363 | 0.460 |
Why?
|
| Retrospective Studies | 9 | 2024 | 8489 | 0.440 |
Why?
|
| Immune Tolerance | 1 | 2015 | 337 | 0.440 |
Why?
|
| Tissue Donors | 5 | 2022 | 463 | 0.430 |
Why?
|
| Tissue Engineering | 1 | 2014 | 181 | 0.430 |
Why?
|
| Aged | 8 | 2024 | 18415 | 0.430 |
Why?
|
| Perfusion | 4 | 2022 | 203 | 0.410 |
Why?
|
| Massachusetts | 2 | 2021 | 33 | 0.380 |
Why?
|
| Heart Transplantation | 4 | 2018 | 705 | 0.370 |
Why?
|
| Tissue and Organ Procurement | 3 | 2022 | 311 | 0.350 |
Why?
|
| Anastomosis, Surgical | 2 | 2021 | 267 | 0.340 |
Why?
|
| Male | 14 | 2024 | 40965 | 0.340 |
Why?
|
| Kidney | 1 | 2014 | 1241 | 0.320 |
Why?
|
| Swine, Miniature | 3 | 2018 | 51 | 0.310 |
Why?
|
| Swine | 4 | 2018 | 555 | 0.300 |
Why?
|
| Female | 12 | 2024 | 44532 | 0.300 |
Why?
|
| Organ Preservation | 3 | 2022 | 83 | 0.300 |
Why?
|
| Middle Aged | 7 | 2021 | 25028 | 0.300 |
Why?
|
| Survival Rate | 2 | 2021 | 1863 | 0.280 |
Why?
|
| Antibodies, Neutralizing | 3 | 2021 | 112 | 0.280 |
Why?
|
| Transplant Recipients | 2 | 2023 | 122 | 0.260 |
Why?
|
| Treatment Outcome | 4 | 2022 | 7993 | 0.250 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 40 | 0.240 |
Why?
|
| Exercise Therapy | 1 | 2024 | 80 | 0.230 |
Why?
|
| Cytokines | 3 | 2022 | 776 | 0.230 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3640 | 0.230 |
Why?
|
| High-Throughput Screening Assays | 1 | 2023 | 55 | 0.230 |
Why?
|
| Cell Culture Techniques | 1 | 2023 | 188 | 0.220 |
Why?
|
| Geriatric Assessment | 1 | 2024 | 166 | 0.220 |
Why?
|
| Pyridones | 1 | 2022 | 51 | 0.210 |
Why?
|
| Vascular Diseases | 1 | 2022 | 121 | 0.200 |
Why?
|
| Laryngostenosis | 1 | 2021 | 16 | 0.200 |
Why?
|
| Immunodominant Epitopes | 1 | 2021 | 19 | 0.200 |
Why?
|
| Reoperation | 2 | 2021 | 597 | 0.200 |
Why?
|
| Imidazoles | 1 | 2022 | 162 | 0.200 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 138 | 0.200 |
Why?
|
| Esophagectomy | 1 | 2021 | 84 | 0.200 |
Why?
|
| Immunization, Passive | 1 | 2020 | 71 | 0.190 |
Why?
|
| Respiratory System | 1 | 2021 | 116 | 0.190 |
Why?
|
| Exercise | 1 | 2024 | 315 | 0.190 |
Why?
|
| Adult | 6 | 2022 | 25648 | 0.180 |
Why?
|
| Transcriptome | 2 | 2021 | 580 | 0.180 |
Why?
|
| Postoperative Hemorrhage | 1 | 2020 | 46 | 0.180 |
Why?
|
| Forced Expiratory Volume | 1 | 2019 | 122 | 0.180 |
Why?
|
| B-Lymphocytes | 2 | 2021 | 724 | 0.180 |
Why?
|
| Morbidity | 1 | 2019 | 148 | 0.170 |
Why?
|
| Esophageal Neoplasms | 1 | 2021 | 321 | 0.170 |
Why?
|
| Incidental Findings | 1 | 2019 | 95 | 0.170 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 231 | 0.170 |
Why?
|
| Atherosclerosis | 1 | 2021 | 244 | 0.170 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 456 | 0.170 |
Why?
|
| Bronchi | 1 | 2019 | 229 | 0.160 |
Why?
|
| Electromagnetic Phenomena | 1 | 2017 | 18 | 0.150 |
Why?
|
| Brain Death | 1 | 2018 | 69 | 0.150 |
Why?
|
| Referral and Consultation | 1 | 2019 | 328 | 0.140 |
Why?
|
| Heart | 2 | 2021 | 539 | 0.140 |
Why?
|
| Transplantation Tolerance | 1 | 2018 | 130 | 0.140 |
Why?
|
| Time Factors | 2 | 2015 | 5210 | 0.140 |
Why?
|
| Ischemia | 1 | 2018 | 243 | 0.140 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 394 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2019 | 1538 | 0.130 |
Why?
|
| Preoperative Care | 1 | 2018 | 397 | 0.130 |
Why?
|
| Major Histocompatibility Complex | 1 | 2015 | 81 | 0.130 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 80 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 2501 | 0.130 |
Why?
|
| Cryopreservation | 1 | 2015 | 69 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 1169 | 0.130 |
Why?
|
| Embolization, Therapeutic | 1 | 2018 | 238 | 0.130 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 1939 | 0.130 |
Why?
|
| Quality of Life | 1 | 2023 | 1585 | 0.130 |
Why?
|
| Histocompatibility Testing | 1 | 2015 | 154 | 0.130 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 1056 | 0.130 |
Why?
|
| Allografts | 1 | 2015 | 172 | 0.120 |
Why?
|
| Isoantibodies | 1 | 2015 | 114 | 0.120 |
Why?
|
| Models, Animal | 1 | 2015 | 263 | 0.120 |
Why?
|
| Liver Transplantation | 1 | 2022 | 1268 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2014 | 221 | 0.120 |
Why?
|
| Public Health | 1 | 2014 | 129 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2019 | 2767 | 0.110 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2013 | 93 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 2438 | 0.100 |
Why?
|
| Hospitalists | 1 | 2013 | 131 | 0.100 |
Why?
|
| Cross Reactions | 2 | 2021 | 106 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2013 | 349 | 0.100 |
Why?
|
| Mutation | 1 | 2022 | 3968 | 0.100 |
Why?
|
| Animals | 5 | 2018 | 26582 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2013 | 373 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2818 | 0.090 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 134 | 0.090 |
Why?
|
| Risk Factors | 1 | 2019 | 5417 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 878 | 0.080 |
Why?
|
| United States | 1 | 2020 | 6672 | 0.080 |
Why?
|
| Endothelin-1 | 2 | 2015 | 41 | 0.060 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 314 | 0.060 |
Why?
|
| Small Molecule Libraries | 1 | 2023 | 61 | 0.060 |
Why?
|
| Gastric Emptying | 1 | 2021 | 23 | 0.050 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 2021 | 8 | 0.050 |
Why?
|
| Receptor, Endothelin A | 1 | 2021 | 22 | 0.050 |
Why?
|
| Epitope Mapping | 1 | 2021 | 16 | 0.050 |
Why?
|
| Neutralization Tests | 1 | 2021 | 77 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2021 | 136 | 0.050 |
Why?
|
| Sexism | 1 | 2021 | 51 | 0.050 |
Why?
|
| Stomach | 1 | 2021 | 108 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2021 | 213 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2021 | 143 | 0.050 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 67 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2021 | 369 | 0.050 |
Why?
|
| Epitopes | 1 | 2021 | 255 | 0.050 |
Why?
|
| Bioethics | 1 | 2020 | 35 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2021 | 152 | 0.050 |
Why?
|
| Bias | 1 | 2020 | 127 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 217 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2020 | 86 | 0.040 |
Why?
|
| Survivors | 1 | 2021 | 226 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 254 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 203 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2021 | 280 | 0.040 |
Why?
|
| Living Donors | 1 | 2022 | 339 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 429 | 0.040 |
Why?
|
| Cell Line | 1 | 2023 | 2468 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 528 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 456 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 258 | 0.040 |
Why?
|
| Liver | 1 | 2022 | 1230 | 0.040 |
Why?
|
| Biopsy | 1 | 2020 | 1163 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 1577 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1384 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 740 | 0.030 |
Why?
|
| Presumed Consent | 1 | 2014 | 1 | 0.030 |
Why?
|
| Disaccharides | 1 | 2014 | 23 | 0.030 |
Why?
|
| Electrolytes | 1 | 2014 | 52 | 0.030 |
Why?
|
| Organ Preservation Solutions | 1 | 2014 | 28 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2014 | 49 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1196 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2014 | 45 | 0.030 |
Why?
|
| Histidine | 1 | 2014 | 55 | 0.030 |
Why?
|
| Mannitol | 1 | 2014 | 49 | 0.030 |
Why?
|
| Glutamates | 1 | 2014 | 89 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 134 | 0.030 |
Why?
|
| Glutathione | 1 | 2014 | 104 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2014 | 157 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2705 | 0.030 |
Why?
|
| Myocardium | 1 | 2015 | 529 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 275 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 4213 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 592 | 0.020 |
Why?
|
| Oxygen | 1 | 2014 | 726 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1683 | 0.020 |
Why?
|